Zobrazeno 1 - 10
of 11
pro vyhledávání: '"HPV PATRICIA Study Group"'
Autor:
Unnop Jaisamrarn, Xavier Castellsagué, Suzanne M Garland, Paulo Naud, Johanna Palmroth, Maria Rowena Del Rosario-Raymundo, Cosette M Wheeler, Jorge Salmerón, Song-Nan Chow, Dan Apter, Julio C Teixeira, S Rachel Skinner, James Hedrick, Anne Szarewski, Barbara Romanowski, Fred Y Aoki, Tino F Schwarz, Willy A J Poppe, F Xavier Bosch, Newton S de Carvalho, Maria Julieta Germar, Klaus Peters, Jorma Paavonen, Marie-Cecile Bozonnat, Dominique Descamps, Frank Struyf, Gary O Dubin, Dominique Rosillon, Laurence Baril, HPV PATRICIA Study Group
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79260 (2013)
BackgroundThe control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and
Externí odkaz:
https://doaj.org/article/f961d1ec4e5d4146871f6301cdfc1d02
Autor:
Apter, Dan, Wheeler, Cosette M, Paavonen, Jorma, Castellsagué, Xavier, Garland, Suzanne M, Skinner, S Rachel, Naud, Paulo, Salmerón, Jorge, Chow, Song-Nan, Kitchener, Henry C, Teixeira, Julio C, Jaisamrarn, Unnop, Limson, Genara, Szarewski, Anne, Romanowski, Barbara, Aoki, Fred Y, Schwarz, Tino F, Poppe, Willy, Bosch, F Xavier, Mindel, Adrian, de Sutter, Philippe, Hardt, Karin, Zahaf, Toufik, Descamps, Dominique, Struyf, Frank, Lehtinen, Matti, Dubin, Gary, for the HPV PATRICIA Study Group
We report final event-driven analysis data on the immunogenicity and efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in young women aged 15-25 years from the PApilloma TRIal against Cancer In young Adults (PATRICIA; NCT001226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1131::902fe75d07c7c911bd9ca390dc2ffd4c
https://lirias.kuleuven.be/handle/123456789/484805
https://lirias.kuleuven.be/handle/123456789/484805
Autor:
Struyf, Frank, Colau, Brigitte, Wheeler, Cosette M., Naud, Paulo Sergio Viero, Garland, Suzanne M., Quint, Wim G. V., Chow, Song-Nan, Salmerón, Jorge, Lehtinen, Matti, Del Rosario-Raymundo, Maria Rowena, Paavonen, Jorma, Teixeira, Júlio César, Germar, Maria Julieta V., Peters, Klaus, Skinner, S. Rachel, Limson, Genara, Castellsague, Xavier, Poppe, Willy A. J., Ramjattan, Brian, Klein, Terry D., Schwarz, Tino F., Chatterjee, Archana, Tjalma, Wiebren A. A., Diaz-Mitoma, Francisco, Lewis, David J. M., Harper, Diane M., Molijn, Anco, Doorn, Leen-Jan van, David, Marie-Pierre, Dubin, Gary, HPV PATRICIA Study Group
Publikováno v:
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
The efficacy of the human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against cervical infections with HPV in the Papilloma Trial against Cancer in Young Adults (PATRICIA) was evaluated using a combination of the broad-spectrum L1-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::8b4aa0cc428128611d618c6e733da8a2
Autor:
Castellsague, Xavier, Naud, Paulo Sergio Viero, Chow, Song-Nan, Wheeler, Cosette M., Germar, Maria Julieta V., Lehtinen, Matti, Paavonen, Jorma, Jaisamrarn, Unnop, Garland, Suzanne M., Salmerón, Jorge, Apter, Dan L., Kitchener, Henry, Teixeira, Júlio César, Skinner, S. Rachel, Limson, Genara, Szarewski, Anne, Romanowski, Barbara, Aoki, Fred Y., Schwarz, Tino F., Poppe, Willy A. J., Bosch, F. Xavier, Carvalho, Newton S. de, Peters, Klaus, Tjalma, Wiebren A. A., Safaeian, Mahboobeh, Raillard, Alice, Descamps, Dominique, Struyf, Frank, Dubin, Gary, Rosillon, Dominique, Baril, Laurence, HPV PATRICIA Study Group
Publikováno v:
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Background. We examined risk of newly detected human papillomavirus (HPV) infection and cervical abnormalities in relation to HPV type 16/18 antibody levels at enrollment in PATRICIA (Papilloma Trial Against Cancer in Young Adults; NCT00122681). Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::c9de55a350543b20a1f3ca9267519468
Autor:
Unnop Jaisamrarn, Xavier Castellsagué, Suzanne M. Garland, Paulo Naud, Johanna Palmroth, Maria Rowena Del Rosario-Raymundo, Cosette M. Wheeler, Jorge Salmerón, Song-Nan Chow, Dan Apter, Julio C. Teixeira, S. Rachel Skinner, James Hedrick, Anne Szarewski, Barbara Romanowski, Fred Y. Aoki, Tino F. Schwarz, Willy A. J. Poppe, F. Xavier Bosch, Newton S. de Carvalho, Maria Julieta Germar, Klaus Peters, Jorma Paavonen, Marie-Cecile Bozonnat, Dominique Descamps, Frank Struyf, Gary O. Dubin, Dominique Rosillon, Laurence Baril, HPV PATRICIA Study Group
Publikováno v:
PLoS ONE, Vol 8, Iss 12 (2013)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::e662c4298593a1bf0b8edcab5997dee5
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878864/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878864/?tool=EBI
Autor:
Lehtinen, Matti, Paavonen, Jorma, Wheeler, Cosette M, Jaisamrarn, Unnop, Garland, Suzanne M, Castellsagué, Xavier, Skinner, S Rachel, Apter, Dan, Naud, Paulo, Salmerón, Jorge, Chow, Song-Nan, Kitchener, Henry, Teixeira, Julio C, Hedrick, James, Limson, Genara, Szarewski, Anne, Romanowski, Barbara, Aoki, Fred Y, Schwarz, Tino F, Poppe, Willy A J, De Carvalho, Newton S, Germar, Maria Julieta V, Peters, Klaus, Mindel, Adrian, De Sutter, Philippe, Bosch, F Xavier, David, Marie-Pierre, Descamps, Dominique, Struyf, Frank, Dubin, Gary, HPV PATRICIA Study Group
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus (HPV) vaccines. Vaccine efficacy against CIN3+, the immediate precursor to invasive cervical c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a443a5c0fccd97d66c5507941c0b3300
https://hdl.handle.net/20.500.14017/bafbf69e-f0fc-467b-aec7-c4169dfd311d
https://hdl.handle.net/20.500.14017/bafbf69e-f0fc-467b-aec7-c4169dfd311d
Autor:
S. R. Skinner, S. M. Garland, I. Denham, M. O'Sullivan, R. Waddell, A. Mindel, null on behalf of the HPV PATRICIA study group
Publikováno v:
Sexual Health. 4:305
Objectives: Previous studies with the HPV-16/18 L1 VLP AS04 vaccine have shown 100% efficacy against HPV 16/18 associated persistent infection and CIN in women with no previous exposure to oncogenic HPV. This interim analysis of a phase III, randomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52060519b0ad4f564f457236f219f4fd
https://doi.org/10.1071/shv4n4ab55
https://doi.org/10.1071/shv4n4ab55
Autor:
Tino F. Schwarz, Terry D. Klein, Archana Chatterjee, Rachel Skinner, Willy Poppe, Paulo Naud, Klaus Peters, Maria Julieta Maria Julieta Germar, Brigitte Desiree Alberte Colau, Marie Pierre David, Cosette M. Wheeler, M. Rowena Del Rosario-Raymundo, Song Nan Chow, Jorma Paavonen, Wim Quint, Leen Jan Van Doorn, Jorge Salmerón, Frank Struyf, Julio Cesar Teixeira, Gary Dubin, Genara Limson, David J. M. Lewis, Brian Ramjattan, Francisco Diaz-Mitoma, Suzanne M. Garland, Xavier Castellsagué, Wiebren A.A. Tjalma, Diane M. Harper, Matti Lehtinen, Anco Molijn
Publikováno v:
Clinical and vaccine immunology
The efficacy of the human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against cervical infections with HPV in the Pa pilloma Tri al against C ancer i n Young A dults (PATRICIA) was evaluated using a combination of the broad-spectru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::624aae16ba8c29275aac00f42769cd4b
https://doi.org/10.1128/cvi.00457-14
https://doi.org/10.1128/cvi.00457-14
Autor:
Anne Szarewski, Song-Nan Chow, Willy Poppe, Matti Lehtinen, D Apter, Tino F. Schwarz, James Hedrick, Karin Hardt, Gary Dubin, Barbara Romanowski, Xavier Castellsagué, Jorge Salmerón, Cosette M. Wheeler, Suzanne M. Garland, S R Skinner, Frank Struyf, Julio Cesar Teixeira, Genara Limson, Unnop Jaisamrarn, Dominique Descamps, Toufik Zahaf, Diane M. Harper, Franz X. Bosch, Fred Y. Aoki, Henry C Kitchener, Paulo Naud, Jorma Paavonen
Publikováno v:
International journal of cancer
In the Phase III PATRICIA study (NCT00122681), the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (Cervarix(®), GlaxoSmithKline Biologicals) was highly efficacious against HPV-16/18 infections and precancerous lesions in women HPV-16/18 de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff80f61efc1be8c3d8054e39d061b07b
https://doi.org/10.1002/ijc.26362
https://doi.org/10.1002/ijc.26362
Autor:
Cosette M, Wheeler, Xavier, Castellsagué, Suzanne M, Garland, Anne, Szarewski, Jorma, Paavonen, Paulo, Naud, Jorge, Salmerón, Song-Nan, Chow, Dan, Apter, Henry, Kitchener, Júlio C, Teixeira, S Rachel, Skinner, Unnop, Jaisamrarn, Genara, Limson, Barbara, Romanowski, Fred Y, Aoki, Tino F, Schwarz, Willy A J, Poppe, F Xavier, Bosch, Diane M, Harper, Warner, Huh, Karin, Hardt, Toufik, Zahaf, Dominique, Descamps, Frank, Struyf, Gary, Dubin, Matti, Lehtinen, S K, Tay
Publikováno v:
The lancet oncology
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the end-of-study analysis after 4 years of follow-up in PATRICIA (PApilloma TRIal against Cancer In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b54b332dfaff0fc26271c410365c8fef
https://hdl.handle.net/10067/1069160151162165141
https://hdl.handle.net/10067/1069160151162165141